참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Chloride | HCID 312 | — |
| 반응물 | N-tert-butylpyrazine-2-carboxamide | HCID 4462842 | — |
| 용매 | Methanol | HCID 887 | — |
| 생성물 | (2S)-N-(1,1-Dimethylethyl)piperazine-2-carboxamide | HCID 9806153 | — |
반응 단계
0.5 g (2.7 mmol) of pyrazinecarboxylic acid tert-butylamide (prepared according to Example 3), 26.9 mg (58 μmol) of bicyclo[2.2.1]hepta-2,5-dienerhodium(I) chloride dimer and 72 mg (121 μmol) of 1-[1 (R)-(dicyclohexylphosphino)ethyl]-2(S)-(diphenylphosphino)ferrocene were placed in an autoclave under argon. After the addition of 10 ml of degassed methanol, the autoclave was flushed three times with argon and twice with hydrogen. A hydrogen pressure of 50 bar was then applied. Hydrogenation was carried out at 70° C. for 20 hours. The autoclave was depressurized and flushed with nitrogen. The solvent was completely distilled off. The yield of the title compound was 0.50 g. A conversion of 80 percent was determined by NMR. The enantiomeric excess (ee) was 77.6 percent according to GC analysis.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05945534 |
|---|
| 출처 데이터셋 | uspto-grants-1999_08 |
|---|
| ORD ID | ord-5c436cb535344985a936f615956edea5 |
|---|
| 출처 메모 | uspto-grants-1999_08 |
|---|